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ABSTRACT
Objectives: Premenstrual Syndrome (PMS) is a cluster of physical and emotional symptoms occurring in the luteal phase 
of the menstrual cycle. The study aim was to determine the relationship between PMS, and state of nutrition expressed as 
Body Mass Index (BMI) and body composition in 18-year-old females. 
Material and methods: The study was conducted on 476 women divided into two groups i.e. those suffering from PMS 
(n = 233) and those without symptoms (n = 243). The women were examined during their luteal phase using bioelectrical 
impedance analysis to determine their body composition. Height and weight were measured using digital medical scales 
with an electronic height rod. BMI was calculated thus: BMI = body mass (weight) (kg)/height (m2). The subjects were di-
vided into two sub-groups: BMI < 25 kg/m2 and BMI ≥ 25 kg/m2. Statistical analysis was carried out using STATISTICA 10 PL 
software and the Mann-Whitney test.
Results: The women with normal BMI suffered from PMS twice as often as the women with BMI ≥ 25 kg/m2 (68.2% vs. 31.8%). 
There were significantly higher values for Fat Mass (FM) (%) (p < 0.01) and FM (kg) (p < 0.001) in women without PMS, and 
significantly higher values for Fat-Free Mass (FFM) (%) (p < 0.001) and Total Body Water (TBW) (%) (p < 0.001) in women 
with PMS. Higher values were reported for FFM (kg) and TBW (kg) (p < 0.05) in girls with PMS and BMI ≥ 25.
Conclusions: These results show PMS is more frequent in patients with BMI < 25, and less frequent in patients with higher 
FM (kg) and FM (%). Moreover, significant frequency of PMS was observed in patients with higher FFM and TBW. Such 
statistical significance was not confirmed in girls with a BMI < 25. 
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INTRODUCTION
Premenstrual Syndrome (PMS) is a cluster of somatic, 
emotional and behavioural symptoms occurring in the lu-
teal phase of the menstrual cycle. Many studies have been 
conducted but the aetiology of PMS remains unknown 
[1–3]. PMS symptoms substantially affect the quality of 
a woman’s life [2, 3].
According to strict diagnostic criteria, an estimated 
2.5–5% of girls and women are affected by PMS. However, 
some researchers maintain that the symptoms of PMS may 
be prevalent in as many as 40–80% of girls and women. Due 
to this considerable discrepancy, it is necessary to make 
the definition of PMS more precise. Patients with PMS ex-
perience mood disturbances together with physical and 
emotional symptoms, which recur in the luteal phase and 
disappear in the follicular phase of the menstrual cycle. No 
other psychiatric or health conditions that might cause simi-
lar symptoms are observed. The symptoms, with irritability 
being a major one, occur to a degree that they impair some 
aspects of a women’s life, in particular, their sexuality. Such 
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symptoms usually last from 10 to 14 days every month. The 
basic diagnostic criteria for PMS include: 
1. Prospectively establishing the timing of the symptoms, 
confirmed by prospective daily ratings for at least two 
menstrual cycles, with changes documented in a diary 
(at least one affective or physical symptom during the 
last five days before menses and remission of the symp-
toms within the first four days of the menses).
2. A 30% increase in the intensity of symptoms in the luteal 
phase, as compared with the follicular phase.
It is made sure that the subjects do not have histories 
of psychiatric disorders or hormonal medication such as 
oral contraceptive pills or irregular menstrual cycles. The 
most common PMS symptoms include physical symptoms: 
breast tenderness or breast pain (mastalgia), accompanied 
by breast swelling and tenderness of the nipples (70%), 
abdominal pains, bloating, abdominal swelling and some-
times constipation (50%), headaches and migraines (30%), 
swelling and weight gain (45%), cramps and back pains, diz-
ziness, digestive disturbances, nausea, vomiting, diarrhoea, 
swelling of extremities (both hands and feet), joint or muscle 
pain, palpitations, frequent micturition, increased thirst, 
decreased alcohol tolerance, and skin lesions. Symptoms 
of chronic diseases are frequently aggravated e.g. allergic 
symptoms, including hay fever, bronchial asthma and al-
lergic dermatitis, chronic digestive disorders and nervous 
system diseases (e.g. epilepsy). Other psychologic and be-
havioural PMS symptoms include: sugar and salt cravings, 
tension or anxiety, irritability, crying and tearfulness, fatigue, 
depressed mood, insomnia or hypersomnia, forgetfulness or 
confusion, panic attacks, aggression and depression [4–9]. 
The prevalence of PMS is related to the ovarian cy-
cle and the influence of oestrogen and progesterone on 
centrally acting neurotransmitters, serotonin and GABA 
(γ-aminobutyric acid). Arguing for this hypothesis is that PMS 
is not prevalent before puberty, during pregnancy and after 
menopause. Oestrogen and progesterone influence sero-
tonin receptors. The evidence suggests that treatment with 
selective serotonin reuptake inhibitors (SSRI PMS) alleviates 
PMS symptoms. Allopregnanolone, a metabolite of proges-
terone, modulates GABA and symptomatic women seem to 
have lower levels of allopregnanolone. Some studies find 
that PMS may be determined by genetic factors; however, 
no specific genotype has been identified yet. Childhood 
emotional experiences are linked with PMS prevalence in 
adulthood. In addition, the occurrence of PMS is influenced 
by lifestyle (physical activity, diet), personality disorders and 
addiction to psychoactive substances, as well as high body 
mass index (BMI) [10–21].
Research has been going on for many years on the 
changes in body composition that are related to age, mal-
nutrition or overnutrition. However, to our knowledge, no 
previous studies have examined whether body composition 
may be a premenstrual syndrome indicator in young women. 
In this study, bioelectrical impedance analysis (BIA) was 
used to assess body composition of the patients [1]. BIA is 
a non-invasive diagnostic method using the ability of tissues 
to impede electric current and providing accurate analysis of 
body composition. BIA approach is also used in total body 
water and fat content measurements [1, 4]. 
Techniques for assessing body composition emerged 
in the first half of the 20th century. Initially, an indirect way 
of this assessment relied on the analysis of body fluids. The 
discovery of deuterium enabled accurate assessment of 
total body water, and the use of other isotopes of hydrogen 
helped to develop assessment techniques of totally replace-
able electrolytes – sodium and potassium. The early studies 
by Barnett and other investigators focused on the relation-
ship between bioelectrical impedance measurements and 
total body water. In the 1970’s, Nyboer et al. started their 
pioneer research on impedance plethysmography, in which 
they highlighted the relationship between the changes in 
body impedance and the changes in pulsatile blood, pulse 
and breathing. Simultaneously, hydrodensitometry was 
being investigated as a method of estimating body com-
position. At the time, most of the body mass measurement 
methods relied on the distinction between the two main 
components i.e. fat and non-fatty matter. Hydrodensitom-
etry apparatus became standard equipment for measuring 
body composition. A distinction was made between fat 
mass (FM) and fat-free mass (FFM). Fat mass components in-
clude triglycerides and lipids but no water or potassium. The 
composition of fat-free mass include 72–74% of water and 
60–66 mmol/kg of potassium. This 2-compartment model 
became a basis for the modern research on body composi-
tion. In the years that followed, a 4-compartment model was 
developed which divided the body into measured water, 
protein, bones, mineral mass (ash mass) and fat. As in the 
2-compartment model, total body potassium (TBK) meas-
urements and total body water (TBW) measurements were 
used to estimate body components. The division based on 
TBK and TBW measurements led to the development of the 
4-compartment model. The 4-compartment model includes: 
FM, BCM (Body Cell Mass), ECW (extracellular water; in girls 
about 45% of TBW) and other fat-free extracellular solids 
(FFECS). Later on, intracellular water (ICW), which constitutes 
approximately 55% of total body water, was distinguished 
from ECW. Bioelectrical impedance (BIA) was first used in the 
mid-1980s. Today many BIA devices are in use, with different 
electrode configurations and different frequencies [1, 4]. 
The objective of the present study was to investigate the 
relationship between state of nutrition, expressed as BMI, 
body composition in 18-year-old girls, and premenstrual 
syndrome prevalence.
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MATERIALS AND METHODS
The study was conducted among the patients of Gy-
naecology and Perinatology Medical Centre in Gynaecology 
and Obstetrics Hospital of Poznan University of Medical Sci-
ences. The sample of 476 Caucasian women aged 18 was di-
vided into two groups: experimental one with PMS (n = 233) 
and controls without PMS (n = 243). 
Diagnosis of PMS in this study was made according 
to the diagnostic criteria suggested by Royal College of 
Obstetricians and Gynaecologists (RCOG) [16].
Testing for PMS included a symptom diary in which the 
patients prospectively recorded the symptoms within two 
full monthly cycles. 
PMS was diagnosed if the patient reported at least one 
of the following symptoms including depression, irritabil-
ity, anxiety, confusion or social withdrawal and one of the 
somatic symptoms (breast tenderness, abdominal bloating, 
headache, swelling of extremities) during the 5 days before 
menses in the two prior menstrual cycles. The patients were 
diagnosed by a practitioner during the medical examination. 
Exclusion criteria were based on the exclusion of disease 
entities that could be similar to PMS, i.e. mental disorders 
such as depression, bipolar disorder, anxiety and personal-
ity disorders, as well as drug dependence, endometriosis, 
thyroid function disorders, allergies, and autoimmune dis-
eases [17].
Body composition was assessed with Tanita MC 
780 device which uses bioelectrical impedance analysis (BIA 
method) [4]. In this model, the accuracy of measurement 
for the individual components, including adipose tissue, 
is 100 grams. The measurements of fat mass FM, fat-free 
mass FFM and total body water TBW have been expressed 
as percentage (%) and kilograms (kg). All the patients had 
their height and body mass measured. Weight was meas-
ured to the nearest 0.1 kg using a SECA 899 digital medical 
scales. Height was measured to the nearest mm with a SECA 
217 stadiometer attached to the scales. The patients were 
asked to remove their shoes and outer garments.
The measurements were taken according to the stand-
ards for anthropometric assessment (The World Health Or-
ganisation, 1987). BMI was calculated as weight in kilograms 
divided by height in metres squared (kg/m2).
The participants were grouped according to their 
BMI: < 25 kg/m2 and BMI ≥ 25 kg/m2.
Statistical analysis was carried out using STATISTICA 10 PL 
software. Due to non-normal distribution and inability to 
ensure constant homogeneity of variances, Mann-Whitney 
test was used to assess parametric differences in PMS and 
non-PMS women. Statistical significance was set at P < 0.5. 
Before the study began, all the patients had been 
informed about the procedures, aims, and scope of the 
study. Informed consent was obtained from all the partici-
pants. The study was approved by the Bioethics Committee 
of Karol Marcinkowski Poznan University of Medical Sciences 
(Resolution No 553/18).
RESULTS 
The study was conducted among 476 women aged 
18 who were divided two groups: women with PMS (n = 233) 
and those without PMS (n = 243). Then, two sub-groups were 
identified: women with BMI < 25 kg/m2 and women with 
BMI ≥ 25 (Tab. 1). It was observed that among the women 
with normal body mass (BMI < 25 kg/m2)), twice as many 
had PMS, compared to those with a BMI ≥ 25 (68.2 vs. 31.8).
Statistically significant differences between PMS and 
non-PMS groups are given in Table 2. 
The parameters for analysis included: fat mass (FM), 
fat-free mass (FFM) and total body water (TBW), expressed 
as percentage and kilograms.
There were statistically significant differences between 
the PMS and non-PMS groups for FM, expressed as per-
centage and kilograms, with significantly higher values for 
women without PMS (p = 0.001 and p = 0.0001 respec-
tively). Higher values for FFM (%) (p = 0.0001) and TBW (%) 
(p = 0.0001) were reported for women with PMS.
As shown in Table 3, there was no statistically significant 
difference in the examined parameters between trials in 
women with PMS and the control group with normal body 
mass i.e. BMI < 25. 
Body composition of the two groups in patients with 
BMI ≥ 25 was compared. Statistically significant differences 
were observed. In women with PMS, higher values were 
recorded both for FFM (%) (p = 0.02) and TBW (kg) (p = 0.02) 
(Tab. 4). 
DISCUSSION 
In the present study we have assessed the state of nu-
trition and body composition in 18-year-old girls, with the 
use of BMI and BIA respectively. The objective of the study 
was to determine the relationship between BMI, fat mass, 
fat-free mass and water with PMS prevalence. 
Our study reported that there was a statistically signifi-
cant relationship between PMS and BMI. PMS is significantly 
Table 1. Characteristics of participants according to PMS prevalence 
and BMI
BMI in kg/m2
prevalence of PMS
yes 
n = 233
no 
n = 243
n [%] n [%]
< 25 159 68.2 127 52.3
≥ 25 74 31.8 116 47.7
Source: authors’ own research
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more prevalent in girls with normal BMI (Tab. 1) and with 
significantly lower FM, higher FFM and higher TBW.
Fat mass average in non-PMS women was approximately 
3 kg higher than in PMS women. Also, non-PMS women had sta-
tistically lower fat-free mass and lower total body water (Tab. 2).
PMS women with BMI ≥ 25 kg/m2 had statistically higher 
fat-free mass (FFM, kg) and water (TBW, %). No such statisti-
cal significance was found in women with BMI < 25.
The present findings are not consistent with the findings 
from several previous studies which concluded that PMS 
is more prevalent in obese women with BMI > 30 [14] and 
BMI > 27.5 kg [15].
These previous studies have relied on the theory that in 
premenstrual period, glucose-induced metabolism of food 
deviates from the brain to the reproductive system and its sur-
roundings including an increase in the level of blood in uterus 
vessels, which provides menstruation. Subsequently, this de-
viation leads to changes in brain control adjustment processes, 
which in turn cause impulsive symptoms characteristic of PMS. 
However, this hypothesis is not fully understood, because it has 
been proven that increased fat deposits compensate for a lack 
of metabolism required by the body and simply enhances 
glucose consumption. Since the premenstrual phase is char-
acterized by a decrease in hormones in the bloodstream, no 
Table 3. Descriptive statistics for body composition parameters analysis in PMS and non-PMS women with BMI < 25 kg/m2 
Parameter Prevalence of PMS n Mean SD Median Min. Max.
Mann-Whitney test*
Z p
FM [kg]
yes 159 14.92 4.49 14.70 2.10 28.10
-0.49 ns
no 127 15.26 5.32 15.20 2.10 27.80
FM [%]
yes 159 25.18 5.52 25.50 5.70 36.20
-1.07 ns
no 127 25.70 6.41 26.70 5.00 38.60
FFM [kg]
yes 159 43.48 5.26 42.70 28.70 70.50
0.67 ns
no 127 42.63 3.85 42.40 30.80 54.30
FFM [%]
yes 159 74.85 5.56 74.58 63.74 94.39
1.08 ns
no 127 74.31 6.40 73.33 61.45 94.99
TBW [kg]
yes 159 31.83 3.85 31.30 21.00 51.60
0.66 ns
no 127 31.21 2.82 31.00 22.60 39.80
TBW [%]
yes 159 54.79 4.04 54.58 46.71 68.98
1.07 ns
no 127 54.41 4.69 53.71 45.02 69.45
* statistically significant, p < 0.05; ns — not statistically significant; SD — standard deviation 
 Source: authors’ own research.
Table 2. Descriptive statistics for body composition parameters analysis in PMS and non-PMS women
Parameter PMS prevalence n Mean SD Median Min. Max.
Mann-Whitney test
Z p
FM [kg]
yes 233 20.2 10.1 17.3 2.1 61.5
-3.29 0.001*
no 243 23.0 10.8 21.2 2.1 61.7
FM [%]
yes 233 29.2 8.2 28.3 5.7 50.1
-3.96 0.0001*
no 243 32.0 8.8 32.1 5.0 53.7
FFM [kg]
yes 233 45.7 6.6 44.3 28.7 70.5
-0.35 ns
no 243 45.4 5.5 45.2 30.8 65.9
FFM [%]
yes 233 70.8 8.2 71.7 50.0 94.4
3.96 0.0001*
no 243 68.0 8.8 67.9 46.3 95.0
TBW [kg]
yes 233 33.5 4.8 32.4 21.0 51.6
-0.35 ns
no 243 33.2 4.0 33.1 22.6 48.2
TBW [%]
yes 233 51.8 6.0 52.4 36.6 69.0
3.95 0.0001*
no 243 49.8 6.5 49.6 33.8 69.5
*statistically significant, p < 0.05; ns — not statistically significant; SD — standard deviation 
Source: authors’ own research
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significant increase in the function of the ovary and the uterus 
at the beginning of and during the next cycle is observed, and 
there is no clear reason for increased metabolic costs which are 
different during the premenstrual phase [16, 18]. This theory 
partly explains the results of our research. 
Moreover, it has to be noted that the cited authors [14, 15] 
previously conducted their studies on younger and old-
er women aged 18–44. Our study group only included 
18-hear-olds.
It is likely that obesity and being overweight will play 
a role in the etiology of PMS, although the relationship 
between PMS and anthropometric indicators in ambigu-
ous. In some studies, BMI is directly or indirectly related to 
the body’s hormonal balance mechanism [14, 19, 20, 22].
Most investigators relate PMS to the falling levels of 
progesterone during the luteal phase of the menstrual cycle, 
which leads to the lower oestrogen/progesterone ratio. One 
of the etiologic theories is related to fluid retention. The 
theory suggests that oestrogen induces increased hepatic 
angiotensinogen synthesis, which results in higher aldos-
terone levels. This in turn, leads to sodium retention and 
potassium-depleting effect. It has also been found that in 
PMS, there is little increase in prolactin levels in the luteal 
phase, which may be the result of abnormalities in the syn-
thesis and the release of dopamine and serotonin. It has 
been proven that dopamine has a direct renal diuretic ef-
fect, whereas serotonin makes kidneys more sensitive [1, 2].
The feeling of pressure in the lower abdomen and low 
back pains result from fluid retention in the uterus and the 
venous stasis in the lesser pelvis. The swelling of central 
nervous system cells is the cause of headaches, dizziness, 
nausea, mental tension, insomnia, anxiety, tendency for 
depression and increased appetite. Weight gain by 2–4 kg 
resolves within the first days of menstruation [2]. 
The results of our study seem to confirm the fluid reten-
tion theory, since statistically significant differences were 
observed in the two study groups for total body water (TBW) 
in kilograms. Higher values were reported for PMS women 
(p < 0.005). This statistical significance was confirmed for 
both the whole study population and form women with 
BMI ≥ 25 kg/m2.
The pathophysiology of premenstrual syndrome is still 
unclear, and its causes may be of multifactorial nature.
Previous studies not very comprehensive assessed body 
composition in relation to PMS, it is impossible then to es-
tablish comparative and evolving nature of this relationship. 
Therefore, it is recommended that further studies should be 
conducted to confirm correlations between the prevalence 
of PMS and body composition expressed as fat mass, fat free 
mass and total body water content. In order to develop and 
understanding of their importance for future treatment of 
women with PMS.
A limited number of previous studies have evaluated 
the relationship between body mass index body composi-
tion and premenstrual syndrome and to our knowledge, 
this is the first study that has investigated the relation-
ship between PMS prevalence, state of nutrition and body 
composition in developmental age girls. Further study is 
recommended to determine the optimal BMI and fat mass 
values, which will help minimize PMS prevalence. 
CONCLUSIONS
Although the pathophysiology behind PMS has not 
been fully explained, it is recommended to assess the state 
Table 4. Descriptive statistics for body composition parameters analysis in PMS and non-PMS women with BMI ≥ 25 kg/m2
Parameter PMS prevalence n Mean SD Median Min. Max.
Mann-Whitney test*
Z p
FM [kg]
yes 74 31.52 9.38 28.90 16.90 61.50
-0.52 ns
no 116 31.54 8.64 30.60 15.20 61.70
FM [%]
yes 74 37.85 5.85 36.95 19.30 50.10
-1.63 ns
no 116 38.87 5.24 39.00 18.70 53.70
FFM [kg]
yes 74 50.58 6.62 49.75 38.50 70.50
2.33 0.02*
no 116 48.45 5.34 47.15 39.60 65.90
FFM [%]
yes 74 62.16 5.86 63.11 49.95 80.76
1.63 ns
no 116 61.13 5.24 60.97 46.27 81.26
TBW [kg]
yes 74 37.03 4.85 36.40 28.20 51.60
2.34 0.02*
no 116 35.47 3.90 34.55 29.00 48.20
TBW [%]
yes 74 45.50 4.29 46.21 36.56 59.11
1.62 ns
no 116 44.75 3.84 44.64 33.84 59.43
*statistically significant, p < 0.05; ns — not statistically significant; SD — standard deviation 
Source: authors’ own research
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of nutrition and body composition which, as the current 
study shows, are related to premenstrual syndrome preva-
lence. Since they are modifiable factors, PMS treatment 
should include a balanced diet and physical activity, which 
will help to modify not only body mass but also fat mass. Fur-
ther studies on PMS women should also offer recommenda-
tions for lifestyle interventions. 
It is also vital to ensure that PMS-related psychosexual 
disorders are diagnosed, and proper treatment is admin-
istered. 
The strengths of our study include sample size 
(476 women) and its homogeneity (all the patients were 
Caucasian women aged 18). A limitation of the study is 
that we did not analyze lifestyle factors such as diet, physi-
cal activity and the use of stimulants, all of which may be 
potentially linked to PMS prevalence. 
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